Role of ATP-sensitive K+ channels in cardiac arrhythmias

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 19, Issue 3, 2014, Pages 237-243

  Nakaya, Haruaki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

J wave syndrome; Kir6.1; Kir6.2

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ION; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MITOCHONDRIAL K(ATP) CHANNEL; POTASSIUM CHANNEL; UK-ATP-1 POTASSIUM CHANNEL;

ACTION POTENTIAL; BRUGADA SYNDROME; CALCIUM CELL LEVEL; CELL METABOLISM; GAIN OF FUNCTION MUTATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEMODYNAMIC STRESS; HUMAN; LOSS OF FUNCTION MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SUDDEN INFANT DEATH SYNDROME; SYMPATHETIC FUNCTION; EXERCISE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY; SARCOLEMMA;

ARRHYTHMIAS, CARDIAC; EXERCISE; HUMANS; KATP CHANNELS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; REPERFUSION INJURY; SARCOLEMMA;

EID: 84899020064     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248413515078     Document Type: Review

References (56)

1. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983 ; 305 (5930). 147-148
2. Inagaki N, Gonoi T, Clement JP, et al. Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor. Science. 1995 ; 270 (5239). 1166-1170
3. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the β-cell sulfonylurea receptor: a regulator of insulin secretion. Science. 1995 ; 268 (5209). 423-426
4. Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol. 2003 ; 81 (2). 133-176
5. Seino S, Miki T. Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice. J Physiol. 2003 ; 554 (pt 2). 295-300
6. Suzuki M, Sasaki N, Miki T, et al. Role of sarcolemmal KATP channel in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest. 2002 ; 109 (4). 509-516
7. O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res. 2004 ; 94 (4). 420-432
8. Foster DB, Ho AS, Rucker J, et al. Mitochondrial ROMK channel is a molecular component of mitoKATP. Circ Res. 2012 ; 111 (4). 446-454
9. Olson TM, Alekseev AE, Moreau C, et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Prac Cardiovasc Med. 2007 ; 4 (2). 110-116
10. Antzelevitch C. Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J. 2012 ; 76 (5). 1054-1065
11. Cole WC, McPherson CD, Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res. 1991 ; 69 (3). 571-581
12. Hiraoka M, Fan Z. Activation of ATP-sensitive outward K+ current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes. J Pharmacol Exp Ther. 1989 ; 250 (1). 278-285
13. Ishida H, Higashijima N, Hirota Y, et al. Nicorandil attenuated the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart. Naunyn Schmiedebergs Arch Pharmacol. 2004 ; 369 (2). 192-197
14. Garlid KD, Paucek P, Yarov-Yarovoy V, et al. cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. possible mechanism of cardioprotection. Circ Res. 1997 ; 81 (6). 1072-1082
15. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?. Circulation. 1998 ; 97 (24). 2463-2469
16. Miki T, Suzuki M, Shibasaki T, et al. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 2002 ; 8 (5). 466-472
17. Das B, Sarkar C, Karanth KS. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits. Naunyn-Schmiedeberg's Arch Pharmacol. 2001 ; 364 (5). 383-396
18. Das B, Sarkar C. Is the sarcolemmal or mitochondrial KATP channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?. Life Sci. 2005 ; 77 (11). 1226-1248
19. Billman GE, Englert HC, Scholkens BA. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther. 1998 ; 286 (3). 1486-1473
20. Billman GE, Houle MS, Englert HC, Gogelein H. Effects of a novel cardioprotective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-β-methoxyethoxyphenyl]sulfonyl] -3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies. J Pharmacol Exp Ther. 2004 ; 309 (1). 182-192
21. Vajda S, Baczko I, Lepran I. Selective cardiac plasma-membrane KATP channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion. Eur J Pharmacol. 2007 ; 577 (1-3). 115-123
22. Saito T, Sato T, Miki T, Seino S, Nakaya H. Role of ATP-sensitive K+ channels in electrophysiological alterations during myocardial ischemia: a study using Kir6.2-null mice. Am J Physiol Heart Circ Physiol. 2005 ; 288 (1). H352 - H357
23. Zingman LV, Hodgson DM, Bast PH, et al. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci. 2002 ; 99 (20). 13278-13283
24. Liu XK, Yamada S, Kane GC, et al. Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia. Diabetes. 2004 ; 53 (suppl 3). S165 - S168
25. Yamada S, Kane GC, Befar A, Liu XK, et al. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 kir6.2-null mutant. J Physiol. 2006 ; 577 (pt 3). 1053-1065
26. Kane GC, Behfar A, Dyer RB, et al. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet. 2006 ; 15 (15). 2285-2297
27. Han J, So I, Kim EY, Earm YE. ATP-sensitive potassium channels are modulated by intracellular lactate in rabbit ventricular myocytes. Pflugers Arch. 1993 ; 425 (5-6). 546-548
28. Marx SO, Kurokawa J, Reiken S, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 2002 ; 295 (5554). 496-499
29. Fedorov VV, Glukhov AV, Ambrosi CM, et al. Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol. 2011 ; 51 (2). 215-225
30. Bauer A, Becker R, Dreyhaupt J, et al. Role of KATP channels in repetitive induction of ventricular fibrillation. Europace. 2007 ; 9 (3). 154-161
31. Taylor TG, Venable PW, Shibayama J, et al. Role of KATP channel in electrical depression and asystole during long-duration ventricular fibrillation in ex vivo canine heart. Am J Physiol Heart Circ Physiol. 2011 ; 302 (11). H2396 - H2409
32. Farid TA, Nair K, Masse S, et al. Role of KATP channels in the maintenance of ventricular fibrillation in cardiomyopathic human hearts. Circ Res. 2011 ; 109 (11). 1309-1318
33. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003 ; 299 (5604). 251-254
34. Christophersen IE, Olesen MS, Liang B, et al. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur Heart J. 2013 ; 34 (20). 1517-1525
35. Olesen MS, Refsgaard L, Holst AG, et al. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc Res. 2013 ; 98 (3). 488-495
36. Olson TM, Alekseev AE, Moreau C, et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Prac Cardiovasc Med. 2007 ; 4 (2). 110-116
37. Honjo H, Boyett MR, Niwa R, et al. Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine. Circulation. 2003 ; 107 (14). 1937-1943
38. Olson TM, Alekseev AE, Liu XK, et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet. 2006 ; 15 (14). 2185-2191
39. Vereckei A, Gogelein H, Wirth KJ, Zipes DP. Effect of the cardioselective, sarcolemmal K(ATP) channel blocker HMR1098 on atrial electrical remodeling during pacing-induced atrial fibrillation in dogs. Cardiovasc Drug Ther. 2004 ; 18 (1). 23-30
40. Brundel BJJM, VanGelder IC, Henning RH, et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol. 2001 ; 37 (3). 926-932
41. Balana B, Dobrev D, Wettwer E, Christ T, Knaut M, Ravens U. Decreased ATP-sensitive K+ current density during chronic human atrial fibrillation. J Mol Cell Cardiol. 2003 ; 35 (12). 1399-1405
42. Mehta MC, Jain AC. Early repolarization on scalar electrocardiogram. Am J Med Sci. 1995 ; 309 (6). 305-311
43. Haïssaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008 ; 358 (19). 2016-2023
44. Brugada P, Burgada J. Right bundle branch block, persistent ST elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992 ; 20 (6). 1391-1396
45. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996 ; 27 (5). 1061-1070
46. Antzelevitch C. Genetic, molecular and cellular mechanisms underlying the J wave syndrome. Circ J. 2012 ; 76 (5). 1054-1065
47. Antzelevitch C, Yan GX. J wave syndromes. from cell to bedside. J Electrocardiol. 2011 ; 44 (6). 656-661
48. Antzelevitch C, Yan GX. J wave syndrome. Heart Rhythm. 2010 ; 7 (4). 549-558
49. Haïssaguerre M, Chatel S, Sacher F, et al. Ventricular fibrillation with prominent early repolarization with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol. 2009 ; 20 (1). 93-98
50. Barajas-Martinez Hu D, Ferrer T, et al. Molecular genetics and functional association of Brugada and early repolarization syndromes with S422 L missense mutation in KCNJ8. Heart Rhythm. 2012 ; 9 (4). 548-555
51. Delaney JT, Muhammad R, Blair MA, et al. A KCNJ8 mutation associated with early repolarization and atrial fibrillation. Europace. 2012 ; 14 (10). 1428-1432
52. Medeiros-Domingo A, Tan BH, Crotti L, et al. Gain-of-function mutation, S422 L, in the KCNJ8-encoded cardiac KATP channel Kir6.1 as a pathogenic substrate for J wave syndrome. Heart Rhythm. 2010 ; 7 (10). 1466-1471
53. Tester DJ, Tan BH, Medeiros-Doming A, Song C, Makielski JC, Ackerman KJ. Loss-of-function mutations in the KCNJ8-encoded Kir6.1 channel and sudden infant death syndrome. Circ Cardiovasc Genet. 2011 ; 4 (5). 510-515
54. Suzuki M, Li RA, Miki T, et al. Functional roles cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res. 2001 ; 88 (6). 570-577
55. Nichols C, Singh GK, Grange DK. KATP channels and cardiovascular disease: suddenly a syndrome. Circ Res. 2013 ; 112 (7). 1059-1072
56. Rines AK, Bayeva M, Ardehali H. A new pROM king for the mitoKATP dance: ROMK takes the lead. Circ Res. 2012 ; 111 (4). 392-393